Antitumor effect of the idiotypic cascade induced by an antibody encapsulated in poly(d,l-lactide-co-glycolide) microspheres
- PMID: 11676862
- PMCID: PMC5926615
- DOI: 10.1111/j.1349-7006.2001.tb01066.x
Antitumor effect of the idiotypic cascade induced by an antibody encapsulated in poly(d,l-lactide-co-glycolide) microspheres
Abstract
A major difficulty encountered during development of antibody vaccines is their weak immunogenicity. In this study, a monoclonal antibody CS20.5 to human breast cancer antigen CA15.3 was coencapsulated in poly(d,l-lactide-co-glycolide) microspheres with monophosphoryl lipid A. The antitumor effect of this formulation was investigated in a murine model. The induced Ab2 biologically mimics antigen as it competed with CA15.3 for the same idiotope on Ab1. Ab3 induction was also observed. After five sequential administrations of encapsulated antibody, mice showed statistically significant tumor regression. These results indicate that this formulation may serve as a potential treatment for breast cancer.
Similar articles
-
Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres.Cancer Immunol Immunother. 1998 Sep;47(1):13-20. doi: 10.1007/s002620050499. Cancer Immunol Immunother. 1998. PMID: 9755874 Free PMC article.
-
Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.Cancer Res. 1995 Apr 1;55(7):1525-30. Cancer Res. 1995. PMID: 7533665
-
Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.Eur J Immunol. 1987 Nov;17(11):1649-52. doi: 10.1002/eji.1830171120. Eur J Immunol. 1987. PMID: 3500066
-
[Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].Zentralbl Gynakol. 1999;121(4):190-5. Zentralbl Gynakol. 1999. PMID: 10355096 Review. German.
-
Anti-idiotype antibody vaccine therapies of cancer.Cancer Treat Res. 1998;94:51-68. doi: 10.1007/978-1-4615-6189-7_4. Cancer Treat Res. 1998. PMID: 9587682 Review. No abstract available.
References
-
- ) Ma , J. , Luo , D. , Kwon , G. S. , Samuel , J. , Noujaim , A. A. and Madiyalakan , R.Use of encapsulated single chain antibodies for induction of anti‐idiotypic humoral and cellular immune responses . J. Pharm. Scl , 87 , 1375 – 1378 ( 1998. ). - PubMed
-
- ) Men , Y. , Thomasin , C. , Merkle , H. P. , Gander , B. and Corradin , G.A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide . Vaccine , 13 , 683 – 689 ( 1995. ). - PubMed
-
- ) Whittum‐Hudson , J. A. , An , L. , Saltzman , W. M. , Prendergast , R. A. and MacDonald , A. B.Oral immunization with an anti‐idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection . Nat. Med. , 10 , 1116 – 1121 ( 1996. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical